Peripheral neuropathy Board decisions

The Board has dismissed the appeals due to the Veteran's death, as they have no jurisdiction to adjudicate claims for service connection.

The Veteran's claims for service connection are being remanded due to the need for further development regarding his exposure to herbicide agents and whether he served in the Republic of Vietnam under the Blue Water Navy Vietnam Veterans Act of 2019. The claims will also be reviewed for secondary service connection.

The Board has dismissed the appeal for service connection of peripheral neuropathy of the bilateral upper extremities due to a withdrawal by the Veteran's representative. The appeals for diabetes and Parkinson's disease are remanded.

The Veteran's diabetes mellitus type two, hypertension, and renal disease are granted service connection. His bilateral lower extremity peripheral neuropathy is also granted service connection. The Veteran's right and left knee patellofemoral syndromes have been granted increased ratings.

The Board has determined that additional evidence is needed to adjudicate the Veteran's claims for service connection for peripheral neuropathy of the upper and lower extremities, as these conditions are secondary to his service-connected diabetes mellitus type II. The case is being remanded for further development.

The Veteran's claims for increased evaluations of his service-connected right and left lower extremity peripheral neuropathy were denied. The Board found that the evidence did not support a finding of more than mild or moderate incomplete paralysis prior to July 27, 2015 and from then on.

The Board denied service connection for ITP, BLE neuropathy, bone marrow abnormalities, and ovarian cancer as a result of exposure to chemicals at Fort McClellan. The Veteran was not diagnosed with any of these conditions during active service or for many years thereafter, and there is no evidence of direct exposure to toxic chemicals.

The Board has remanded the case due to incomplete records and insufficient examination. The Veteran's claim for service connection for neuropathy of the bilateral feet as secondary to his service-connected bilateral pes planus is pending.

The Board has remanded the claims for service connection due to exposure to herbicide agents and toxins, including DMII, peripheral neuropathy of upper and lower extremities, and hysterectomy. The claims are being reviewed again as there is insufficient evidence regarding the Veteran's exposure at Fort McClellan.

The Board has determined that the previous remand instructions were not followed and requires a new VA examination to address the Veteran's claims for bilateral hand conditions, including vasospastic arterial disease/Raynaud's disease and polyneuropathy/peripheral neuropathy.

The Board has remanded several issues related to the Veteran's claims for service connection, including those involving diabetes mellitus and hypertension. The main issue is whether new and material evidence has been submitted to reopen these claims.

The Board has granted service connection for peripheral vascular disease, but has remanded the issues of service connection for left lower extremity neuropathy, left upper extremity neuropathy, right lower extremity neuropathy, right upper extremity neuropathy, and retinopathy due to lack of medical evidence.

The Board has dismissed the Veteran's appeals for increased evaluations of his service-connected diabetes mellitus, left and right upper extremity peripheral neuropathy as he withdrew these claims at a hearing. The Veteran was granted entitlement to a total disability rating based on individual unemployability (TDIU) due to his service-connected disabilities.

The Board has decided that further development is needed to determine if the Veteran was exposed to Agent Orange during his service aboard USS Bennington (CVS-20). The claims for diabetes mellitus, hypertension, peripheral neuropathies, and erectile dysfunction are remanded due to this exposure determination.

The Veteran's service-connected right lower neuropathy, including peripheral neuropathy of the right femoral nerve, was granted an increased evaluation to 20 percent for the entire period on appeal from March 18, 1998.

The Veteran's peripheral neuropathy of the right and left lower extremities is currently rated as 10 percent disabling. The Board has ordered a new examination to assess the severity of his disability, including changes in his Neurontin prescription and clarification on the impact of his diabetic peripheral neuropathy versus residual manifestations of his stroke.

The Veteran's claims for service connection for hypertension and ischemic heart disease were denied as there was no evidence of current disabilities meeting the criteria for VA purposes. The claim for TDIU was also denied due to lack of a current disability that precludes gainful employment.

The Veteran's service-connected peripheral neuropathy in both lower extremities is granted with a rating of 40 percent.

The Board has remanded the claims for service connection due to exposure to herbicide agents, including diabetes mellitus, ischemic heart disease, hypertension, peripheral neuropathy of the upper and lower extremities, and erectile dysfunction. The decision is pending further development.

The Veteran's claim for service connection for radiculopathy of the right lower extremity and left lower extremity is denied.,The Veteran's claim for service connection for diabetic peripheral neuropathy of the right upper extremity and left upper extremity due to diabetes mellitus, type II, is denied.